Relationship between the uptake of calcium or phosphorus and alkaline phosphatase activity induced by certain modulators in rat organs.
The effects of phorbol ester or calmodulin on the calcium and phosphorus uptakes by rat tissues and their relationship to the alkaline phosphatase activity (ALP) were investigated in vivo. In rat tissues, ALP activity and calcium uptake in the duodenum and liver were clearly induced by phorbol ester treatment, whereas in the calvarium and ileum they were decreased. Phosphorus uptake was increased by the administration of phorbol ester only in the calvarium. In rats pretreated with an injection of indomethacin as an inhibitor of prostaglandin-synthesizing enzyme, the selective uptake of calcium by phorbol ester was eliminated in the duodenum and liver, as was the ALP activity. In contrast, rats showed a marked increase in ALP activity in the ileum after calmodulin treatment. Moreover, the increased uptake of calcium after calmodulin treatment was clearly seen in the ileum, calvarium, and kidney, and an increased uptake in phosphorus was seen in the duodenum, ileum, and calvarium, but not in kidney. Furthermore, prior injection of W-7 or calmidazolium as an antagonist of calmodulin, reduced the increased ALP activities and the uptake of calcium in all organs tested, but did not reduce the increased phosphorus uptake by the calvarium. Consequently, it is suggested that calcium uptake under the above conditions correlated well with changes in the ALP activity; however, phosphorus uptake seemed to be less in accord with ALP activity. The amount of tested other mineral metabolic markers suggests that the Ca uptake and ALP activity induced by certain effectors regulate 1,25(OH)2D3 level by the modulation of 25(OH)D3-1 alpha-hydroxylase activity.
Nagata
A
A
Department of Biochemistry, Saitama Medical School, Japan.
Komoda
T
T
Sakagishi
Y
Y
D000469:Alkaline Phosphatase / Q000378:metabolism*; D000818:Animals; D002116:Calcitonin / Q000494:pharmacology; D002117:Calcitriol / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism / Q000493:pharmacokinetics*; D002132:Calcium Radioisotopes / Q000378:metabolism / Q000493:pharmacokinetics; D002147:Calmodulin / Q000494:pharmacology*; D003577:Cytochrome P-450 Enzyme System; D004386:Duodenum / Q000378:metabolism; D004789:Enzyme Activation / Q000187:drug effects; D007082:Ileum / Q000378:metabolism; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D010703:Phorbol Esters / Q000494:pharmacology*; D010758:Phosphorus / Q000378:metabolism / Q000493:pharmacokinetics*; D010761:Phosphorus Radioisotopes / Q000378:metabolism / Q000493:pharmacokinetics; D051381:Rats; D011919:Rats, Inbred Strains; D012886:Skull / Q000378:metabolism; D013250:Steroid Hydroxylases / Q000378:metabolism; D065668:Vitamin D3 24-Hydroxylase
D002132:Calcium Radioisotopes; D002147:Calmodulin; D010703:Phorbol Esters; D010761:Phosphorus Radioisotopes; D010758:Phosphorus; D002116:Calcitonin; D003577:Cytochrome P-450 Enzyme System; D013250:Steroid Hydroxylases; D065668:Vitamin D3 24-Hydroxylase; D000469:Alkaline Phosphatase; D002117:Calcitriol; D002118:Calcium